Publikationen von Galip S. Aslan

Aslan, G. S.; Jae, N.; Manavski, Y.; Fouani, Y.; Shumliakivska, M.; Kettenhausen, L.; Kirchhof, L.; Guenther, S.; Fischer, A.; Luxan, G. et al.; Dimmeler, S.: Malat1 deficiency prevents neonatal heart regeneration by inducing cardiomyocyte binucleation. JCI INSIGHT 8 (5), e162124 (2023)

Cattaneo, P.; Hayes, M. G. B.; Baumgarten, N.; Hecker, D.; Peruzzo, S.; Aslan, G. S.; Kunderfranco, P.; Larcher, V.; Zhang, L.; Contu, R. et al.; Fonseca, G.; Spinozzi, S.; Chen, J.; Condorelli, G.; Dimmeler, S.; Schulz, M. H.; Heinz, S.; Guimaraes-Camboa, N.; Evans, S. M.: DOT1L regulates chamber-specific transcriptional networks during cardiogenesis and mediates postnatal cell cycle withdrawal. NATURE COMMUNICATIONS 13 (1), 7444 (2022)

Cremer, S.; Pilgram, L.; Berkowitsch, A.; Stecher, M.; Rieg, S.; Shumliakivska, M.; Bojkova, D.; Wagner, J. U. G.; Aslan, G. S.; Spinner, C. et al.; Luxan, G.; Hanses, F.; Dolff, S.; Piepel, C.; Ruppert, C.; Guenther, A.; Ruethrich, M. M.; Vehreschild, J. J.; Wille, K.; Haselberger, M.; Heuzeroth, H.; Hansen, A.; Eschenhagen, T.; Cinatl, J.; Ciesek, S.; Dimmeler, S.; Borgmann, S.; Zeiher, A.: Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease. PLOS ONE 16 (10), e0258684 (2021)

Wagner, J. U. G.; Bojkova, D.; Shumliakivska, M.; Luxan, G.; Nicin, L.; Aslan, G. S.; Milting, H.; Kandler, J. D.; Dendorfer, A.; Heumueller, A. W. et al.; Fleming, I.; Bibli, S.-I.; Jakobi, T.; Dieterich, C.; Zeiher, A. M.; Ciesek, S.; Cinatl, J.; Dimmeler, S.: Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. BASIC RESEARCH IN CARDIOLOGY 116 (1), 42 (2021)

Aslan, G. S.; Polat, F.; Eren, S. N.; Yucel, D.; Arbatli, S.; Cumbul, A.; Kocabas, F.: Identification of Novel and Potent Modulators Involved in Neonatal Cardiac Regeneration. PEDIATRIC CARDIOLOGY (2021)

Bojkova, D.; Wagner, J. U. G.; Shumliakivska, M.; Aslan, G. S.; Saleem, U.; Hansen, A.; Luxan, G.; Gunther, S.; Pham, M. D.; Krishnan, J. et al.; Harter, P. N.; Ermel, U. H.; Frangakis, A. S.; Milting, H.; Zeiher, A. M.; Klingel, K.; Cinatl, J.; Dendorfer, A.; Eschenhagen, T.; Tschoepe, C.; Ciesek, S.; Dimmeler, S.: SARS-CoV-2 infects and induces cytotoxic effacts in human cardiomyocytes. CARDIOVASCULAR RESEARCH 116 (14), S. 2207 - 2215 (2020)

Bojkova, D.; Wagner, J. U. G.; Shumliakivska, M.; Aslan, G. S.; Saleem, U.; Hansen, A.; Luxan, G.; Gunther, S.; Pham, M. D.; Krishnan, J. et al.; Harter, P. N.; Ermel, U. H.; Frangakis, A. S.; Milting, H.; Zeiher, A. M.; Klingel, K.; Cinatl, J.; Dendorfer, A.; Eschenhagen, T.; Tschoepe, C.; Ciesek, S.; Dimmeler, S.: SARS-CoV-2 infects and induces cytotoxic effacts in human cardiomyocytes. CARDIOVASCULAR RESEARCH 116 (14), S. 2207 - 2215 (2020)

Turan, R. D.; Albayrak, E.; Uslu, M.; Siyah, P.; Alyazici, L. Y.; Kalkan, B. M.; Aslan, G. S.; Yucel, D.; Aksoz, M.; Tuysuz, E. C. et al.; Meric, N.; Durdagi, S.; Gulbas, Z.; Kocabas, F.: Development of Small Molecule MEIS Inhibitors that modulate HSC activity. SCIENTIFIC REPORTS 10 (1), 7994 (2020)